Team members

Sabrina Moyo

Coordinator (UiB, Norway)

Favorite pathogen or disease:

Kamija Phiri

Scientific Lead and Co-Investigator (TRUE, Malawi)

Kamija is responsible for coordinating the scientific aspects of the project, ensuring that Work Package Leads are meeting their timelines and deliverables.

Kamija is a professor in clinical epidemiology with interest in treatment and prevention of malaria and the interface between iron and disease. He leads clinical trials across Malawi, Uganda and Kenya.

Favorite pathogen or disease: “Malaria – very common in my country and is preventable.”

Joel Manyahi

Co-Investigator (MUHAS, Tanzania)

Joel oversees the planning, coordination and implementation of the clinical trial and its associated sub-studies. This includes ensuring compliance with study protocols, ethical and regulatory requirements and Good Clinical Practice standards. He also ensures high-quality data collection, participant safety and integration of findings from the sub-studies to strengthen the overall scientific impact of the project.

Joel is an associate professor and clinical microbiologist with expertise in infectious diseases, clinical microbiology and antimicrobial resistance (AMR). His research focuses on the epidemiology, diagnosis, prevention and control of infectious diseases, particularly sepsis, hospital-acquired infections and AMR in resource-limited settings. He has extensive experience in surveillance of infectious diseases and AMR, antimicrobial stewardship and implementation of observational and interventional studies aimed at improving patient outcomes and informing public health policy.

Favorite pathogen or disease: “Sepsis in neonates and children.”

Frédéric Ello

Co-Investigator (PAC-CI, Ivory Coast)

Favorite pathogen or disease:

Said Aboud

Co-Investigator (NIMR, Tanzania)

Favorite pathogen or disease:

Lucinda Manda-Taylor

Co-Investigator (TRUE, Malawi)

Lucinda’s role on the project is to conduct qualitative research in order to understand to what degree health providers, caregivers and policy makers consider probiotics as a useful and valuable intervention which will improve children’s health, and the feasibility of accommodating it in their routine practice and policy documents.

Lucinda is a global health researcher and bioethicist with extensive experience in implementation research in low-resource settings, focusing on equitable and evidence-informed health interventions in maternal and child health, malaria, anaemia in pregnancy and mental health. She provides leadership in interdisciplinary research, capacity strengthening and postgraduate mentorship, with a strong track record of securing and managing international research grants and generating policy-relevant evidence.

Favorite pathogen or disease: “None, really. They’re all nuisances.”

Francis Fredrick

Co-Investigator (MUHAS, Tanzania)

Favorite pathogen or disease:

Iain Johnston

Co-Investigator (UiB, Norway)

Favorite pathogen or disease:

Bjørn Blomberg

Co-Investigator (UiB, Norway)

Favorite pathogen or disease:

Doreen Pamba

Co-Investigator (NIMR, Tanzania)

Favorite pathogen or disease:

Anani Badjé

Co-Investigator (PAC-CI, Ivory Coast)

Favorite pathogen or disease:

Raoul Moh

Co-Investigator (PAC-CI, Ivory Coast)

Favorite pathogen or disease:

Nina Langeland

Co-Investigator (UiB, Norway)

Nina is a senior consultant who brings in decades of experience and high competence in trial design and trial leadership.

Nina is a professor of infectious diseases at the University of Bergen, with expertise in outbreak research, antimicrobial resistance and viral infections. She has broad leadership experience and serves as the chair of Regional committee for medical and health research ethics and chair of European Pandemic Preparedness Collaboration.

Favorite pathogen or disease: “Outbreaks of any pathogen are my favorites, because it is challenging and chaotic!”

Rebecca Jane Cox

Co-Investigator (UiB, Norway)

Rebecca’s role on the project is to lead the evaluation of systemic and mucosal rotavirus-specific immune responses.

Rebecca is a professor of medical virology at the University of Bergen and head of the Influenza Centre at Haukeland University Hospital. She leads a translational vaccinology research program that integrates state-of-the-art immunology with human clinical studies, with a vision of reducing the global burden of viral diseases through improved vaccines and immunological understanding. She serves in advisory roles with international health organizations, including the WHO, EU and European Medicines Agency. She is a trustee and chair of the Education Committee for the International Society for Respiratory Viruses, where she is passionate about training the next generation of scientists.

Favorite pathogen or disease: “Influenza as it is always suprising us and I will never be unemployed!”

Amani Mori

Co-Investigator (UiB, Norway)

Favorite pathogen or disease:

Glory Mzembe

Trial Manager (TRUE, Malawi)

Favorite pathogen or disease:

Robert Michael Clarke

Financial Advisor

Favorite pathogen or disease:

Olivera Bozickovic

Administration and Communication Manager

Favorite pathogen or disease: “Still in the process of choosing, give me a year.”